GlassScriptPhysician profile
Sophia Joseph
NPI 1700509221
$1,246.78
in general payments reported to CMS, 2019-2025
18 companies · $549 in 2025
The $549 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $142 · 2024: $556 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,246.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $248.26 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Novo Nordisk INC | $245.74 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $147.09 | 2023-2024 | Rexulti |
| Sanofi-Aventis U.S. LLC | $121.85 | 2024 | |
| Pfizer INC. | $69.14 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.99 | 2024-2025 | Jardiance |
| Glaxosmithkline, LLC. | $62.90 | 2024-2025 | Shingrix |
| Seqirus USA INC | $49.50 | 2024-2025 | Flucelvax, Fluad |
| Exact Sciences Corporation | $44.43 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $31.38 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $25.07 | 2025 | |
| Mallinckrodt Hospital Products INC. | $23.93 | 2024 | Terlivaz |
| Amgen INC. | $20.39 | 2024 | Prolia, Evenity |
| Dynavax Technologies Corporation | $20.37 | 2024 | Heplisav-B |
| Averitas Pharma INC. | $19.08 | 2024 | Qutenza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.96 | 2024 | Breztri |
| Nestle Healthcare Nutrition INC. | $17.96 | 2023 | |
| Abbvie INC. | $16.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sophia Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.